• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO

    Alveo Technologies Announces New Executive Leadership
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Paragon Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Paragon Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Emerging Technologies for Precision-Based Cancer Diagnostics

    Future innovations feature diagnostic and treatment methods that detect and target cancer.

    Emerging Technologies for Precision-Based Cancer Diagnostics
    Paul Crowe, CEO, NuView Life Sciences05.19.17
    The monetary costs of cancer are well over $87 billion in the United States, and even more costly is the loss of life, which is anticipated to be 600,920 Americans this year. Out of all deaths in the United States, 25 percent of them are due to some form of cancer. When focusing on breast cancer alone, it is estimated that there will be a quarter of a million new cases diagnosed this year and 40,450 women will die. Financially speaking, the yearly cost of over-diagnosis and false-positive cancer screenings of women age 40-59 is $4 billion. When it comes to prostate cancer, more than 161,000 new cases are anticipated and approximately 26,730 people are expected to die from it this year.
     
    Although it is an attempt to diagnose cancer as early as possible, mammography screening is not breast cancer prevention. Oftentimes, these screenings can lead to over-diagnosis and overtreatment as well as severe anxiety and depression, which tend to be side effects of cancer diagnosis. In addition, a U.S. government laboratory found that the radiation from tests like the mammogram can change the environment around the breast cells. Within a few weeks after exposure, breast cells start to prematurely age and can be filled with pre-cancerous mutated cells from the radiation.
     

    Paul Crowe, CEO, NuView Life Sciences
    The prostate-specific antigen (PSA) test that has been used for quite some time to detect prostate cancer has been criticized for years. After studying prostate tissue samples collected over the 20 years that the high PSA test result has been the standard for prostate removal, a group of Stanford scientists concluded that the PSA test doesn’t indicate anything more than the size of the prostate gland. Many experts agree that PSA testing tends to be unreliable and useless in accurately diagnosing prostate cancer. Of the men who initially test negative for prostate cancer, 33 percent actually have cancer that has been missed during testing. If the PSA test does come back positive, a biopsy is usually the next step, which can cause more issues, including infection. Instead of the harm that having and being diagnosed with cancer can invoke, there are some substantial medical advances.
     
    There are many research and development innovators hard at work coming up with solutions that will push cancer healthcare toward a precision-based model. For example, a group of biochemists at Purdue University discovered a way to detect elusive substances in blood that may signal the presence of cancer and possibly other diseases as well.
     
    A new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests that the advancement of precision medicine is at a point where a majority of children with brain tumors will be positively impacted. Findings from the largest clinical study testing pediatric brain tumors resulted in showing that it is clinically feasible for genetic abnormalities to be found and the results can help guide the patient’s treatment as well. In the past decade, treatment of certain types of leukemia, digestive system tumors, and breast cancer, among other malignancies, have been found to significantly improve treatment with targeted therapies.
     
    What’s more, targeted cancer diagnostic and treatment methods can provide patients with more accurate results and better care, as well as lower costs. This innovative technology can quickly identify and treat many types of malignant cancers. For the first time ever, doctors can assess the lowest minimum treatment necessary to provide a high-quality life for affected persons.
     
    These developments in precision-based cancer diagnostics and therapeutics, like simple blood and urine tests, will increase accuracy, improve patient outcomes and quality of life, along with saving billions of dollars for patients, third-party payers, and the healthcare system.
     

    Paul Crowe is CEO of NuView Life Sciences and managing partner of San Diego Gamma Knife Center. Crowe is an experienced healthcare executive who, over the past 40 years, participated in the commercialization of new diagnostic imaging technologies such as diagnostic ultrasound, magnetic resonance imaging and positron emission tomography (PET). These technologies provided physicians with better tools to more effectively diagnose and subsequently treat chronic human diseases, improve patient outcomes, and lower healthcare costs.
     
    Related Searches
    • purdue
    • first
    • technologies
    • testing
    Related Knowledge Center
    • Diagnostics
      Loading, Please Wait..

      Trending
      • The Future Of Biomedical Engineering Advancements
      • Cirtec Medical Corporation Acquires Precision Components Business From QMD
      • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
      • A New Approach To Post-Market Surveillance
      • Philips Names New Supervisory Board Chairman
      Breaking News
      • Coloplast Launches New Catheter in the U.S.
      • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
      • NAMSA Relaunches Medtech Outsourcing Solution
      • Rollomatic Inc. Welcomes Joe Kane as CEO
      • Alveo Technologies Announces New Executive Leadership
      View Breaking News >
      CURRENT ISSUE

      November 2022

      • MPO's 2022 Year in Review
      • Fine Print: A Discourse on Additive Manufacturing
      • Grab and Go: Examining the Thrombectomy Device Market
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Dr. Ranjini Murthy Joins Azelis Americas as SVP of Commercial and Digital Excellence
      Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
      Berry Health Benefits Symposium Includes Panel on Dietary Supplements
      Coatings World

      Latest Breaking News From Coatings World

      Evonik, Partners Launch PlasCO₂ Project for C4 Chemicals Production
      Masco Corporation Reaches $5 Million Milestone in Grant Program
      Arkema Partners with Research Institute to Open New Lab in France
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      NAMSA Relaunches Medtech Outsourcing Solution
      Rollomatic Inc. Welcomes Joe Kane as CEO
      Alveo Technologies Announces New Executive Leadership
      Contract Pharma

      Latest Breaking News From Contract Pharma

      iuvo BioScience Appoints Industry Exec to Lead Lab Biz
      Seqens Opens Flagship R&D Center in Greater Boston
      Azelis Americas Appoints Ranjini Murthy Commercial, Digital Excellence SVP
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      U.S. Prestige Beauty Industry Sales Revenue Grew 15% in 2022
      Personal Care Market Forecasted to Grow at CAGR of 6.4% from 2022-2027
      P&G Designs Recyclable Pump Dispenser
      Happi

      Latest Breaking News From Happi

      Nutricosmetics & Wellness Market Expected to Grow 5% by 2033
      Anastasia Beverly Hills Celebrates 25th Anniversary
      Henkel Honors Leading Suppliers During American Cleaning Institute Convention Week
      Ink World

      Latest Breaking News From Ink World

      Early-Bird Registration Opens for Print UV 2023
      Arkema Partners with Research Institute to Open Lab in France
      White Inorganic Pigments Market Worth $29.5 Billion by 2026: MarketsandMarkets
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 23rd Global Release Liner Industry Conference & Exhibition
      Color-Logic certifies Ecofoil digital labestock for cut sheet printers
      Brandywine Label Printing names Dave Rosen new president
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Ahlstrom Launches New Generation FluoroFree Technology
      Berry to Begin Production at India Healthcare Hub Early This Year
      FiltXPO to be Held in October
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Mobi-C Cervical Disc Replacement Procedures Top 200,000
      OPUM, Corflex Global Partner on Knee Assessment Technology
      ODT's Most-Read Stories This Week—Jan. 28
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Textiles are Smarter with Durak SilverPro Conductive Threads
      Arkema Partners with Research Institute to Open Lab in Mulhouse, France
      Veridos to Become Majority Shareholder in NetSeT

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login